| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2011PLoSO...624950W |
| P356 | DOI | 10.1371/JOURNAL.PONE.0024950 |
| P953 | full work available at URL | http://dx.plos.org/10.1371/journal.pone.0024950 |
| https://europepmc.org/articles/PMC3184096 | ||
| https://europepmc.org/articles/PMC3184096?pdf=render | ||
| https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0024950&type=printable | ||
| P932 | PMC publication ID | 3184096 |
| P698 | PubMed publication ID | 21980368 |
| P5875 | ResearchGate publication ID | 51700033 |
| P50 | author | Martin E Gleave | Q88152299 |
| Kristopher Dennis | Q96044361 | ||
| P2093 | author name string | James Morris | |
| Yuwei Wang | |||
| Yuzhuo Wang | |||
| Akira Watahiki | |||
| Peter W. Gout | |||
| Helena M. O'Dwyer | |||
| P2860 | cites work | Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor | Q24319189 |
| A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
| Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells | Q24604908 | ||
| Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. | Q53311174 | ||
| Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer. | Q54503070 | ||
| MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets | Q57200273 | ||
| Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenografts | Q64387019 | ||
| Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models | Q81120942 | ||
| Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA | Q83378068 | ||
| miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells | Q24613084 | ||
| miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis | Q24613599 | ||
| The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 | Q24617130 | ||
| The UCSC Genome Browser database: update 2011 | Q24625811 | ||
| Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes | Q24628676 | ||
| Putative tumor suppressor miR‐145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 gene | Q24632934 | ||
| Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells | Q24646863 | ||
| A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis | Q24649156 | ||
| miRBase: tools for microRNA genomics | Q24649872 | ||
| Cancer statistics, 2010 | Q27860525 | ||
| Functional siRNAs and miRNAs Exhibit Strand Bias | Q27861038 | ||
| Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation | Q28236026 | ||
| Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma | Q28254781 | ||
| Myc-modulated miR-9 makes more metastases | Q28273857 | ||
| Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer | Q28291502 | ||
| Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin | Q28294196 | ||
| miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells | Q28473023 | ||
| miRDB: a microRNA target prediction and functional annotation database with a wiki interface | Q28754510 | ||
| Control of translation and mRNA degradation by miRNAs and siRNAs | Q29614239 | ||
| MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells | Q29616080 | ||
| Endogenous human microRNAs that suppress breast cancer metastasis | Q29617352 | ||
| microRNA-34a is tumor suppressive in brain tumors and glioma stem cells | Q30428366 | ||
| Analysis of microarray data using Z score transformation | Q30787499 | ||
| miRanalyzer: a microRNA detection and analysis tool for next-generation sequencing experiments | Q33443641 | ||
| hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. | Q33699231 | ||
| MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers. | Q34124451 | ||
| Dynamic isomiR regulation in Drosophila development | Q34134968 | ||
| miR-145-dependent targeting of Junctional Adhesion Molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness | Q34136241 | ||
| Complexity of the microRNA repertoire revealed by next-generation sequencing | Q34140539 | ||
| miRNA control of tumor cell invasion and metastasis | Q34179359 | ||
| miRNAs on the move: miRNA biogenesis and the RNAi machinery | Q34320973 | ||
| Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes | Q34544350 | ||
| Critical determinants of metastasis | Q34654980 | ||
| Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer | Q34803786 | ||
| Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells | Q34912570 | ||
| miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. | Q34952175 | ||
| miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells | Q34988143 | ||
| Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence | Q34991210 | ||
| Genetic alterations in hormone-refractory recurrent prostate carcinomas | Q35753171 | ||
| MiPred: classification of real and pseudo microRNA precursors using random forest prediction model with combined features | Q35914053 | ||
| An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells | Q36288990 | ||
| The mighty mouse: genetically engineered mouse models in cancer drug development | Q36568461 | ||
| Connective tissue growth factor (CTGF) and cancer progression | Q37214721 | ||
| ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis | Q37302910 | ||
| Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis | Q37368106 | ||
| Metastamir: the field of metastasis-regulatory microRNA is spreading | Q37373263 | ||
| miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer | Q37375623 | ||
| MicroRNAs in cancer: small molecules with a huge impact | Q37474280 | ||
| Towards the definition of prostate cancer-related microRNAs: where are we now? | Q37589112 | ||
| CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis | Q37652169 | ||
| Emerging role of microRNAs in prostate cancer: implications for personalized medicine. | Q37720811 | ||
| Therapeutic targeting of the prostate cancer microenvironment | Q37785480 | ||
| Advances in Whole Genome Sequencing Technology | Q37807055 | ||
| Widespread deregulation of microRNA expression in human prostate cancer. | Q38297946 | ||
| Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells | Q38340382 | ||
| Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis | Q38413261 | ||
| miR‐125b promotes growth of prostate cancer xenograft tumor through targeting pro‐apoptotic genes | Q39649207 | ||
| miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression | Q39658971 | ||
| TGF-beta promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways | Q39816223 | ||
| The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras | Q39860132 | ||
| miR-449a targets HDAC-1 and induces growth arrest in prostate cancer | Q39878284 | ||
| MicroRNA profile analysis of human prostate cancers | Q39925866 | ||
| ASAP1, a gene at 8q24, is associated with prostate cancer metastasis | Q39976234 | ||
| Biomarkers for prostate cancer | Q40033885 | ||
| MicroRNA expression profiling in prostate cancer | Q40110318 | ||
| An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line. | Q40374898 | ||
| Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis | Q42166576 | ||
| Development and characterization of efficient xenograft models for benign and malignant human prostate tissue | Q42473593 | ||
| Lung cancer xenografting alters microRNA profile but not immunophenotype | Q42553888 | ||
| The microRNA profile of prostate carcinoma obtained by deep sequencing | Q43852104 | ||
| Virally mediated inhibition of Bax in leukocytes promotes dissemination of murine cytomegalovirus | Q43898073 | ||
| Prediction of both conserved and nonconserved microRNA targets in animals. | Q45964956 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| microRNA | Q310899 | ||
| neoplastic gene expression regulation | Q66660300 | ||
| P304 | page(s) | e24950 | |
| P577 | publication date | 2011-09-30 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | MicroRNAs associated with metastatic prostate cancer | |
| MicroRNAs Associated with Metastatic Prostate Cancer | |||
| P478 | volume | 6 |
| Q38434637 | Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration. |
| Q38971323 | Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2. |
| Q62570667 | Animal Models of Metastasis |
| Q43619546 | Array Comparative Genomic Hybridization: An Overview of Protocols, Applications, and Technology Trends |
| Q55361958 | Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model. |
| Q92676056 | Circulating microRNAs in plasma before and after radical prostatectomy |
| Q37081843 | Circulating microRNAs predict biochemical recurrence in prostate cancer patients |
| Q97523674 | Clinical significance of miR-1180-3p in hepatocellular carcinoma: a study based on bioinformatics analysis and RT-qPCR validation |
| Q35110766 | Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer |
| Q45837542 | Comparison of miRNA and gene expression profiles between metastatic and primary prostate cancer |
| Q33571906 | Computational identification of mutually exclusive transcriptional drivers dysregulating metastatic microRNAs in prostate cancer |
| Q34778053 | Constructing higher-order miRNA-mRNA interaction networks in prostate cancer via hypergraph-based learning |
| Q50124176 | DNA methylation alterations induced by transient exposure of MCF-7 cells to maghemite nanoparticles |
| Q36463537 | Design and construction of translational medicine platform for urologic oncology |
| Q34396793 | Detecting microRNAs of high influence on protein functional interaction networks: a prostate cancer case study |
| Q53088153 | Diagnostic and Prognostic Value of miR-1287 in Colorectal Cancer |
| Q42362681 | Diagnostic value of microRNAs in prostate cancer patients with prostate specific antigen (PSA) levels between 2, and 10 ng/mL. |
| Q87200433 | Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status |
| Q36166856 | Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer |
| Q53259995 | Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis |
| Q37040838 | ERBB4 confers metastatic capacity in Ewing sarcoma |
| Q41143586 | Effect of SMYD3 on the microRNA expression profile of MCF-7 breast cancer cells |
| Q37139536 | Effective classification of microRNA precursors using feature mining and AdaBoost algorithms |
| Q39037597 | Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient-derived, advanced prostate cancer tissue xenograft model |
| Q39077807 | Entangling Relation of Micro RNA-let7, miRNA-200 and miRNA-125 with Various Cancers |
| Q31161553 | Epigenetic regulation of thyroid hormone receptor beta in renal cancer. |
| Q39117782 | Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer |
| Q37999504 | Epithelial immune cell-like transition (EIT): A proposed transdifferentiation process underlying immune-suppressive activity of epithelial cancers |
| Q34712579 | Estrogen-dependent dynamic profile of eNOS-DNA associations in prostate cancer |
| Q90184894 | Expression of miR-148b-3p is correlated with overexpression of biomarkers in prostate cancer |
| Q36524796 | Expression profiling of selected microRNA signatures in plasma and tissues of Saudi colorectal cancer patients by qPCR. |
| Q38457785 | GATA2 as a potential metastasis-driving gene in prostate cancer |
| Q33811802 | Heterogeneity of miRNA expression in localized prostate cancer with clinicopathological correlations |
| Q34488314 | High-Throughput miRNA Sequencing Reveals a Field Effect in Gastric Cancer and Suggests an Epigenetic Network Mechanism |
| Q37718438 | Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer |
| Q49330777 | Identification of candidate genes that may contribute to the metastasis of prostate cancer by bioinformatics analysis |
| Q35475008 | Identification of microRNAs linked to regulators of muscle protein synthesis and regeneration in young and old skeletal muscle |
| Q35806390 | In vitro and in vivo model systems used in prostate cancer research |
| Q37437986 | Increased miR-449a expression in colorectal carcinoma tissues is inversely correlated with serum carcinoembryonic antigen |
| Q39001625 | Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies. |
| Q42282866 | Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression. |
| Q37108412 | Investigation of the molecular mechanisms underlying metastasis in prostate cancer by gene expression profiling |
| Q35795725 | MetastamiRs: non-coding MicroRNAs driving cancer invasion and metastasis |
| Q39385197 | MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma |
| Q39139064 | MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A. |
| Q35687197 | MicroRNA Expression Profile in Penile Cancer Revealed by Next-Generation Small RNA Sequencing. |
| Q35163033 | MicroRNA Regulating Glutathione S-Transferase P1 in Prostate Cancer |
| Q38719379 | MicroRNA-101 inhibits proliferation, migration and invasion in osteosarcoma cells by targeting ROCK1. |
| Q88122807 | MicroRNA-1277 Inhibits Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells by Targeting and Suppressing BMP4 Expression and Reflects the Significant Indicative Role in Hepatocellular Carcinoma Pathology and Diagnosis After Magnetic R |
| Q36025254 | MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma |
| Q64230278 | MicroRNA-4719 and microRNA-6756-5p Correlate with Castration-Resistant Prostate Cancer Progression through Interleukin-24 Regulation |
| Q91822425 | MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1 |
| Q37983956 | MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics |
| Q27008271 | MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African Americans |
| Q42388428 | MicroRNAs-208b-3p, 204-5p, 129-2-3p and 3065-5p as predictive markers of oral leukoplakia that progress to cancer |
| Q36224845 | MicroRNA‑361‑5p suppresses cancer progression by targeting signal transducer and activator of transcription 6 in non‑small cell lung cancer |
| Q39673894 | Next generation patient-derived prostate cancer xenograft models |
| Q38586823 | Non-coding RNAs deregulation in oral squamous cell carcinoma: advances and challenges |
| Q27011225 | Noncoding RNAs in cancer and cancer stem cells |
| Q38216129 | Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies. |
| Q36424755 | Pharmacogene regulatory elements: from discovery to applications |
| Q36820516 | Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer |
| Q34558708 | Polymorphisms in the gene regions of the adaptor complex LAMTOR2/LAMTOR3 and their association with breast cancer risk |
| Q39289831 | Poly‐gene fusion transcripts and chromothripsis in prostate cancer |
| Q34946579 | Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors |
| Q28594351 | Profiling of T helper cell-derived small RNAs reveals unique antisense transcripts and differential association of miRNAs with argonaute proteins 1 and 2 |
| Q26782492 | Prognostic Role of MicroRNA-126 for Survival in Malignant Tumors: A Systematic Review and Meta-Analysis |
| Q41902787 | Prostate cancer metastasis-driving genes: hurdles and potential approaches in their identification |
| Q39231676 | Protein network-based Lasso regression model for the construction of disease-miRNA functional interactions |
| Q36439912 | Regulators of gene expression as biomarkers for prostate cancer |
| Q37534719 | Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients |
| Q38288544 | Role of epithelial mesenchymal transition in prostate tumorigenesis |
| Q38264776 | Role of miRNA in head and neck squamous cell carcinoma |
| Q90657651 | Role of miRNA-182 and miRNA-187 as potential biomarkers in prostate cancer and its correlation with the staging of prostate cancer |
| Q38237787 | Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis. |
| Q38086009 | Roles of microRNAs during prostatic tumorigenesis and tumor progression |
| Q37718420 | Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients |
| Q90017873 | Single nucleotide alterations in MicroRNAs and human cancer-A not fully explored field |
| Q33862088 | Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer |
| Q33921151 | Systematic identification and characterization of RNA editing in prostate tumors |
| Q33648775 | TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells |
| Q92637550 | The Panel of 12 Cell-Free MicroRNAs as Potential Biomarkers in Prostate Neoplasms |
| Q64060035 | The Role of MicroRNAs in Hepatoblastoma Tumors |
| Q38654296 | The cross talk between long, non-coding RNAs and microRNAs in gastric cancer |
| Q35919291 | The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer. |
| Q33848134 | The role of GATA2 in lethal prostate cancer aggressiveness |
| Q38221290 | The role of miRNAs in cancer: from pathogenesis to therapeutic implications |
| Q38808905 | The role of microRNAs in bone metastasis |
| Q42220108 | Translational bioinformatics for diagnostic and prognostic prediction of prostate cancer in the next-generation sequencing era. |
| Q49578235 | Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer |
| Q37211956 | USP2a alters chemotherapeutic response by modulating redox. |
| Q35051338 | Using context-specific effect of miRNAs to identify functional associations between miRNAs and gene signatures |
| Q85282162 | [Epigenetic regulation of urological tumors. Importance for prognosis and metastasis] |
| Q38738394 | miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin |
| Q38173789 | miR-126 in human cancers: clinical roles and current perspectives |
| Q35742473 | miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression |
| Q34366475 | miR-205 is frequently downregulated in prostate cancer and acts as a tumor suppressor by inhibiting tumor growth |
| Q30580665 | miRDeep*: an integrated application tool for miRNA identification from RNA sequencing data |
| Q39383167 | miRNA-29b Suppresses Prostate Cancer Metastasis by Regulating Epithelial–Mesenchymal Transition Signaling |
| Q38031424 | miRNAs as biomarkers in prostate cancer |
| Q94526757 | microRNA Expression Profiling in Young Prostate Cancer Patients |
| Q39152581 | microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells |
| Q39266073 | microRNA-34a Sensitizes Lung Cancer Cell Lines to DDP Treatment Independent of p53 Status |
| Q38375325 | microRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition |
| Q47708532 | microRNA-503 suppresses the migration, proliferation and colony formation of prostate cancer cells by targeting tumor protein D52 like 2. |
| Q36250216 | microRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma. |
| Q38015027 | microRNAs in cancer management. |
Search more.